Page last updated: 2024-10-29

ketamine and Wolff-Parkinson-White Syndrome

ketamine has been researched along with Wolff-Parkinson-White Syndrome in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reina, R1
Navas, E1
Marín, J1
Muñoz, M1
Sánchez-Peña, J1

Other Studies

1 other study available for ketamine and Wolff-Parkinson-White Syndrome

ArticleYear
[Diagnosis of Wolff-Parkinson-White Syndrome during ketamine anesthesia].
    Revista espanola de anestesiologia y reanimacion, 1998, Volume: 45, Issue:9

    Topics: Adolescent; Anesthetics, Dissociative; Electrocardiography; Humans; Ketamine; Male; Ulna Fractures;

1998